Luis Cano

Luis Cano
French Institute of Health and Medical Research | Inserm · Unit of Liver, Metabolisms and Cancer

MD Phd

About

42
Publications
6,467
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
387
Citations
Introduction
Luis Cano currently works at the Foie, Métabolisme, Cancer - INSERM U991, Université de Rennes 1.
Additional affiliations
April 2016 - August 2016
September 2016 - present
Université de Rennes 1
Position
  • PhD Student
March 2015 - May 2015
National Cancer Institute (USA), National Institutes of Health
Position
  • Researcher
Education
September 2016 - November 2019
Université de Rennes 1
Field of study
  • Fisiopathology and molecular mechanism of liver cancer
July 2012 - July 2015
National University of San Marcos
Field of study
  • Pathology
April 2004 - December 2011
Universidad San Pedro
Field of study
  • Medicine

Publications

Publications (42)
Article
Full-text available
The global pandemic of metabolic diseases has increased the incidence of hepatocellular carcinoma (HCC) in the context of non‐alcoholic steatohepatitis (NASH). The downregulation of the E3 ubiquitin ligase TRIM21 has been linked to poor prognosis in different cancers including HCC. In order to investigate the role of TRIM21 in liver cancer progress...
Article
Background aims: Hepatocellular carcinoma (HCC), the third cause of cancer-related death, arises in the context of liver fibrosis (LF). Although HCC is generally poorly fibrogenic, some tumors harbor focal intratumor extracellular matrix (ECM) deposits, called fibrous nests. To date, the molecular composition and the clinical relevance of these EC...
Article
Full-text available
Background Perioperative decrease of albumin (ΔAlb) appeared as a promising predictor of complications after digestive surgery, but its role after liver surgery remains unclear. This study aimed to analyze whether and how ΔAlb can be used to predict complications after liver surgery. Methods A bicentric retrospective analysis of patients undergoin...
Article
Background: Liver resection is a curative treatment for hepatocellular carcinoma (HCC) and an alternative to liver transplantation (LT). However, post-liver resection recurrence rates remain high. This study aimed to determine whether liver stiffness measurement (LSM) correlated with recurrence and to propose a method for predicting HCC recurrence...
Article
Full-text available
Angiotensin-converting enzyme 2 (ACE2) is the receptor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus disease 2019 (COVID-19). Transmembrane serine protease 2 (TMPRSS2) is a coreceptor. Abnormal hepatic function in COVID-19 suggests specific or bystander liver disease. Because liver cancer cells express the...
Article
Full-text available
Background: It has previously been demonstrated that a fraction of patients with hepatocellular carcinoma (HCC) > 10 cm can benefit from liver resection. However, there is still a lack of effective decision-making tools to inform intervention in these patients. Methods: We analysed a comprehensive set of clinical data from 234 patients who under...
Article
Full-text available
Raman spectroscopy is an imaging technique that has been applied to assess molecular compositions of living cells to characterize cell types and states. However, owing to the diverse molecular species in cells and challenges of assigning peaks to specific molecules, it has not been clear how to interpret cellular Raman spectra. Here, we provide fir...
Preprint
Full-text available
Angiotensin-converting enzyme 2 (ACE2) is the receptor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus disease 2019 (COVID-19).Transmembrane serine protease 2 (TMPRSS2) is a coreceptor.Abnormal hepatic function in COVID-19 suggests specific or bystander liver disease.Because liver cancer cells express the ACE...
Article
Introduction L’inscription sur liste d’attente de transplantation hépatique (TH) pour CHC requiert un score AFP ≤ 2. Il est connu que le nombre de nodules a, en soi, une valeur pronostique négative mais il n’a pas été clairement rapporté si ce nombre de nodules avait également une valeur pronostique parmi les patients ayant un score AFP ≤ 2. Patie...
Article
Rationnel La résection hépatique est un traitement curatif du carcinome hépatocellulaire (CHC) chez des patients sélectionnés, mais le taux de récidive demeure élevé (près de 2/3 des patients récidivent à 5 ans). Notre objectif était de proposer un score prédictif de récidive selon des facteurs exclusivement préopératoires, afin d’améliorer la séle...
Article
Contexte Une étude a rapporté les résultats des résections R1vasc par rapport à R1par dans le cadre du cholangiocarcinome intrahépatique (iCCA), sans différence claire entre les deux types de résection R1. Patients et méthodes Nous avons examiné 81 patients consécutifs réséqués pour iCCA entre 2013–2019 dans notre centre et analysé leur radicalité...
Article
Full-text available
We have previously described a form of hepatocellular carcinoma (HCC) in non-cirrhotic liver (HCC-NC) developed by Peruvian patients. We analyzed the metallomic profile in hepatic tissues from two independent cohorts exhibiting HCC-NC. Clinical, histopathological data, and HCC and non-tumoral liver (NTL) samples of 38 Peruvian and 38 French HCC-NC...
Article
Full-text available
Hepatocellular carcinoma (HCC) usually afflicts individuals in their maturity after a protracted liver disease. Contrasting with this pattern, the age structure of HCC in Andean people displays a bimodal distribution with half of the patients developing HCC in adolescence and early adulthood. To deepen our understanding of the molecular determinant...
Article
Background: In France, the listing for liver transplantation (LT) for hepatocellular carcinoma (HCC) requires an AFP score ≤2. This study evaluates if the number of nodules assessed immediately before LT has a prognostic value among patients already listed within AFP score. Patients and methods: Among 143 recipients transplanted with an AFP scor...
Preprint
Full-text available
Our group has previously described a particular form of Hepatocellular carcinoma (HCC) developed in non-cirrhotic liver (HCC-NC) developed in Peruvian patients Our aim is to analyze the HCC-NC from clinical-biological findings in two different cohorts (Peruvian and French) and the link with metallomic profile. Clinical, histopathological and also t...
Article
IntroductionCurative treatment of perihilar tumors requires major hepatectomy responsible for high morbidity and mortality. Current nomograms are based on definitive pathological analysis, not usable for patient selection. Our aim was to propose preoperative predictors for severe morbidity (Dindo–Clavien ≥3) and mortality at sixth month after resec...
Article
Introduction: The incidence of primary non-function (PNF) after liver transplantation (LT) remains a major concern with the increasing use of marginal grafts. Indocyanine green (ICG) fluorescence is an imaging technique used in hepatobiliary surgery and LT. Because few early predictors are available, we aimed to quantify in real time the fluoresce...
Article
Full-text available
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer worldwide, as a result of a late diagnosis and limited therapeutic options. Tumour microenvironment (or stroma) plays a key role in cancer onset and progression and constitutes an intrinsic histological hallmark of PDAC. Thus we hypothesised that relevant prognostic biomarkers and therapeut...
Article
Background The curative treatment of perihilar cholangiocarcinomas and centrally located intrahepatic cholangiocarcinomas often requires major hepatectomy preceded by portal vein embolization. This strategy, however, is associated with a high rate of dropouts before operation or failure of resection at the time of operative exploration. We aimed to...
Article
Background Posthepatectomy decompensation remains a frequent and poor outcome after hepatectomy, but its prediction is still inaccurate. Liver stiffness measurement can predict posthepatectomy decompensation, but there is a so-called “gray zone” that requires another predictor. Because splenomegaly is an objective sign of portal hypertension, we hy...
Article
Full-text available
In Peru, hepatocellular carcinoma (HCC) arises in young non-cirrhotic patients. Hepatitis B virus (HBV) is suspected to be the prominent etiological agent. We thus performed a comprehensive molecular study of HBV infection in 65 Peruvian HCC patients. Only 51% were considered as persistently infected at the onset. HBV DNA was found by PCR in the tu...
Article
Full-text available
We previously described a divergent clinical and molecular presentation of hepatocellular carcinoma (HCC) in Peru. The present study aimed to further characterize the tissue features associated with this singular nosological form of HCC in order to gain insight into the natural history of the disease. We performed an exploratory analysis of the his...
Article
Full-text available
Aim: Upper alveolar ridge and hard palate squamous cancer is an infrequent malignancy. We evaluated factors associated with neck involvement and with p16-staining. Methods: Head and neck squamous-cell carcinoma (SCC) patients who went to Head and Neck Department between 1997 and 2011 were screened, and 73 resected upper alveolar ridge and 5 hard pa...
Article
Full-text available
Purpose: Acral lentiginous melanoma (ALM) is a poor prognosis subtype and is the most prevalent in non-Caucasian populations. The presence of tumor infiltrating lymphocytes (TILs) has been associated with poor prognosis in melanoma. A large cohort of ALM cases was studied to determine status of TIL and its association with outcome. Methods: All...
Article
Full-text available
Aim: We compared different methodologies to evaluate Ki67 in neuroendocrine neoplasia (NEN). Patients & methods: ki67 was evaluated using three methods in 70 NEN cases: manual-count, eyeballed estimate made by three pathologists and ImmunoRatio-software. Manual-count was the standard method and agreement with it was evaluated through intraclass cor...
Article
Full-text available
In the developing world, most patients with hepatocellular carcinoma present with advanced-stage disease, considered to be incurable based on current therapeutic algorithms. Here, we demonstrate that curative liver resection is achievable in a portion of Peruvian patients not addressed by these treatment algorithms. We conducted a retrospective coh...
Data
Full-text available
RESUMEN Con el objetivo de describir las características clínico-patológicas de los casos de porocarcinoma ecrino (PE) registrados en el Instituto Nacional de Enfermedades Neoplásicas (INEN), se realizó un estudio trasversal que incluyó todos los casos entre 1998-2009. Para ello se realizó una revisión de fichas clínico-patológicas y una nueva lect...
Article
In order to describe the clinical-pathological characteristics of the cases of Eccrine Porocarcinoma (EP) found in the Instituto Nacional de Enfermedades Neoplásicas (INEN), a cross-sectional study was carried out, including all EP cases recorded between 1998 and 2009. A revision of the clinical-pathological records indentified and a new reading of...
Article
Full-text available
Con el objetivo de describir las características clínico-patológicas de los casos de porocarcinoma ecrino (PE) registrados en el Instituto Nacional de Enfermedades Neoplásicas (INEN), se realizó un estudio trasversal que incluyó todos los casos entre 1998-2009. Para ello se realizó una revisión de fichas clínico-patológicas y una nueva lectura de l...

Questions

Questions (4)
Question
are those methods the same ?
Question
I have 2 types of samples (control and cases) and I would like make an analysis for determinate how different are.
Question
I need some software for RAMAN data analysis, I prefer some good R package
Question
Hi, I need a lot of help for processing RAMAN Spectra data (in R if is possible) ? I am new in this field but I would like to know more about it!
Thanks so much!

Network

Cited By